Global Androgen Receptor Antagonist Supply, Demand and Key Producers, 2023-2029
The global Androgen Receptor Antagonist market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Androgen receptor (AR) is an important target of prostate cancer drugs, and its structure plays an important guiding role in drug development. The androgen receptor consists of 4 structural domains and 8 exons, which are N-terminal binding domain (NTD, exon 1), DNA binding domain (DBD, exon 2-3), hinge region ( HR, exon 4), C-terminal binding domain (LBD, exons 5-8), nuclear localization signal (NLS) is a dichotomous motif contained within exons 3 and 4. The LBD contains a buried hormone-binding pocket (HBP) and a transcriptional activation domain, AF2. AF2 plays an important role in the formation of homodimers, AF2 contains helices 3, 4, 5 and 12 (H3, H4, H5, H12), H12 can change position when ligand binds, when ligand binds to the binding pocket Upon binding, H12 folds back closer to the binding site, preventing ligand disengagement. Non-steroidal AR antagonists avoid the common hormone-like toxic side effects of steroidal AR antagonists, expand clinical applications, and are currently the most commonly used prostate cancer drugs in the United States.
This report studies the global Androgen Receptor Antagonist production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Androgen Receptor Antagonist, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Androgen Receptor Antagonist that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Androgen Receptor Antagonist total production and demand, 2018-2029, (K Units)
Global Androgen Receptor Antagonist total production value, 2018-2029, (USD Million)
Global Androgen Receptor Antagonist production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Androgen Receptor Antagonist consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Androgen Receptor Antagonist domestic production, consumption, key domestic manufacturers and share
Global Androgen Receptor Antagonist production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Androgen Receptor Antagonist production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Androgen Receptor Antagonist production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Androgen Receptor Antagonist market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Inc, Sanofi, Astellas Pharma Inc, Pfizer, Johnson & Johnson, Bayer, Hinova, Jiangsu Hengrui Pharmaceuticals Co., Ltd and Kintor Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Androgen Receptor Antagonist market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Androgen Receptor Antagonist Market, By Region:
1. How big is the global Androgen Receptor Antagonist market?
2. What is the demand of the global Androgen Receptor Antagonist market?
3. What is the year over year growth of the global Androgen Receptor Antagonist market?
4. What is the production and production value of the global Androgen Receptor Antagonist market?
5. Who are the key producers in the global Androgen Receptor Antagonist market?
6. What are the growth factors driving the market demand?
Androgen receptor (AR) is an important target of prostate cancer drugs, and its structure plays an important guiding role in drug development. The androgen receptor consists of 4 structural domains and 8 exons, which are N-terminal binding domain (NTD, exon 1), DNA binding domain (DBD, exon 2-3), hinge region ( HR, exon 4), C-terminal binding domain (LBD, exons 5-8), nuclear localization signal (NLS) is a dichotomous motif contained within exons 3 and 4. The LBD contains a buried hormone-binding pocket (HBP) and a transcriptional activation domain, AF2. AF2 plays an important role in the formation of homodimers, AF2 contains helices 3, 4, 5 and 12 (H3, H4, H5, H12), H12 can change position when ligand binds, when ligand binds to the binding pocket Upon binding, H12 folds back closer to the binding site, preventing ligand disengagement. Non-steroidal AR antagonists avoid the common hormone-like toxic side effects of steroidal AR antagonists, expand clinical applications, and are currently the most commonly used prostate cancer drugs in the United States.
This report studies the global Androgen Receptor Antagonist production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Androgen Receptor Antagonist, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Androgen Receptor Antagonist that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Androgen Receptor Antagonist total production and demand, 2018-2029, (K Units)
Global Androgen Receptor Antagonist total production value, 2018-2029, (USD Million)
Global Androgen Receptor Antagonist production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Androgen Receptor Antagonist consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Androgen Receptor Antagonist domestic production, consumption, key domestic manufacturers and share
Global Androgen Receptor Antagonist production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Androgen Receptor Antagonist production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Androgen Receptor Antagonist production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Androgen Receptor Antagonist market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Inc, Sanofi, Astellas Pharma Inc, Pfizer, Johnson & Johnson, Bayer, Hinova, Jiangsu Hengrui Pharmaceuticals Co., Ltd and Kintor Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Androgen Receptor Antagonist market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Androgen Receptor Antagonist Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- First Generation Inhibitors
- Second Generation Inhibitors
- Prostate Cancer
- Breast Cancer
- Other
- Merck & Co., Inc
- Sanofi
- Astellas Pharma Inc
- Pfizer
- Johnson & Johnson
- Bayer
- Hinova
- Jiangsu Hengrui Pharmaceuticals Co., Ltd
- Kintor Pharma
1. How big is the global Androgen Receptor Antagonist market?
2. What is the demand of the global Androgen Receptor Antagonist market?
3. What is the year over year growth of the global Androgen Receptor Antagonist market?
4. What is the production and production value of the global Androgen Receptor Antagonist market?
5. Who are the key producers in the global Androgen Receptor Antagonist market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Androgen Receptor Antagonist Introduction
1.2 World Androgen Receptor Antagonist Supply & Forecast
1.2.1 World Androgen Receptor Antagonist Production Value (2018 & 2022 & 2029)
1.2.2 World Androgen Receptor Antagonist Production (2018-2029)
1.2.3 World Androgen Receptor Antagonist Pricing Trends (2018-2029)
1.3 World Androgen Receptor Antagonist Production by Region (Based on Production Site)
1.3.1 World Androgen Receptor Antagonist Production Value by Region (2018-2029)
1.3.2 World Androgen Receptor Antagonist Production by Region (2018-2029)
1.3.3 World Androgen Receptor Antagonist Average Price by Region (2018-2029)
1.3.4 North America Androgen Receptor Antagonist Production (2018-2029)
1.3.5 Europe Androgen Receptor Antagonist Production (2018-2029)
1.3.6 China Androgen Receptor Antagonist Production (2018-2029)
1.3.7 Japan Androgen Receptor Antagonist Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Androgen Receptor Antagonist Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Androgen Receptor Antagonist Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Androgen Receptor Antagonist Demand (2018-2029)
2.2 World Androgen Receptor Antagonist Consumption by Region
2.2.1 World Androgen Receptor Antagonist Consumption by Region (2018-2023)
2.2.2 World Androgen Receptor Antagonist Consumption Forecast by Region (2024-2029)
2.3 United States Androgen Receptor Antagonist Consumption (2018-2029)
2.4 China Androgen Receptor Antagonist Consumption (2018-2029)
2.5 Europe Androgen Receptor Antagonist Consumption (2018-2029)
2.6 Japan Androgen Receptor Antagonist Consumption (2018-2029)
2.7 South Korea Androgen Receptor Antagonist Consumption (2018-2029)
2.8 ASEAN Androgen Receptor Antagonist Consumption (2018-2029)
2.9 India Androgen Receptor Antagonist Consumption (2018-2029)
3 WORLD ANDROGEN RECEPTOR ANTAGONIST MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Androgen Receptor Antagonist Production Value by Manufacturer (2018-2023)
3.2 World Androgen Receptor Antagonist Production by Manufacturer (2018-2023)
3.3 World Androgen Receptor Antagonist Average Price by Manufacturer (2018-2023)
3.4 Androgen Receptor Antagonist Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Androgen Receptor Antagonist Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Androgen Receptor Antagonist in 2022
3.5.3 Global Concentration Ratios (CR8) for Androgen Receptor Antagonist in 2022
3.6 Androgen Receptor Antagonist Market: Overall Company Footprint Analysis
3.6.1 Androgen Receptor Antagonist Market: Region Footprint
3.6.2 Androgen Receptor Antagonist Market: Company Product Type Footprint
3.6.3 Androgen Receptor Antagonist Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Androgen Receptor Antagonist Production Value Comparison
4.1.1 United States VS China: Androgen Receptor Antagonist Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Androgen Receptor Antagonist Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Androgen Receptor Antagonist Production Comparison
4.2.1 United States VS China: Androgen Receptor Antagonist Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Androgen Receptor Antagonist Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Androgen Receptor Antagonist Consumption Comparison
4.3.1 United States VS China: Androgen Receptor Antagonist Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Androgen Receptor Antagonist Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Androgen Receptor Antagonist Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Androgen Receptor Antagonist Production Value (2018-2023)
4.4.3 United States Based Manufacturers Androgen Receptor Antagonist Production (2018-2023)
4.5 China Based Androgen Receptor Antagonist Manufacturers and Market Share
4.5.1 China Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Androgen Receptor Antagonist Production Value (2018-2023)
4.5.3 China Based Manufacturers Androgen Receptor Antagonist Production (2018-2023)
4.6 Rest of World Based Androgen Receptor Antagonist Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Androgen Receptor Antagonist Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Androgen Receptor Antagonist Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Androgen Receptor Antagonist Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 First Generation Inhibitors
5.2.2 Second Generation Inhibitors
5.3 Market Segment by Type
5.3.1 World Androgen Receptor Antagonist Production by Type (2018-2029)
5.3.2 World Androgen Receptor Antagonist Production Value by Type (2018-2029)
5.3.3 World Androgen Receptor Antagonist Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Androgen Receptor Antagonist Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Prostate Cancer
6.2.2 Breast Cancer
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Androgen Receptor Antagonist Production by Application (2018-2029)
6.3.2 World Androgen Receptor Antagonist Production Value by Application (2018-2029)
6.3.3 World Androgen Receptor Antagonist Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck & Co., Inc
7.1.1 Merck & Co., Inc Details
7.1.2 Merck & Co., Inc Major Business
7.1.3 Merck & Co., Inc Androgen Receptor Antagonist Product and Services
7.1.4 Merck & Co., Inc Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck & Co., Inc Recent Developments/Updates
7.1.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi Androgen Receptor Antagonist Product and Services
7.2.4 Sanofi Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 Astellas Pharma Inc
7.3.1 Astellas Pharma Inc Details
7.3.2 Astellas Pharma Inc Major Business
7.3.3 Astellas Pharma Inc Androgen Receptor Antagonist Product and Services
7.3.4 Astellas Pharma Inc Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Astellas Pharma Inc Recent Developments/Updates
7.3.6 Astellas Pharma Inc Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Androgen Receptor Antagonist Product and Services
7.4.4 Pfizer Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Details
7.5.2 Johnson & Johnson Major Business
7.5.3 Johnson & Johnson Androgen Receptor Antagonist Product and Services
7.5.4 Johnson & Johnson Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Johnson & Johnson Recent Developments/Updates
7.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.6 Bayer
7.6.1 Bayer Details
7.6.2 Bayer Major Business
7.6.3 Bayer Androgen Receptor Antagonist Product and Services
7.6.4 Bayer Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bayer Recent Developments/Updates
7.6.6 Bayer Competitive Strengths & Weaknesses
7.7 Hinova
7.7.1 Hinova Details
7.7.2 Hinova Major Business
7.7.3 Hinova Androgen Receptor Antagonist Product and Services
7.7.4 Hinova Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Hinova Recent Developments/Updates
7.7.6 Hinova Competitive Strengths & Weaknesses
7.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd
7.8.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Details
7.8.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
7.8.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product and Services
7.8.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
7.8.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd Competitive Strengths & Weaknesses
7.9 Kintor Pharma
7.9.1 Kintor Pharma Details
7.9.2 Kintor Pharma Major Business
7.9.3 Kintor Pharma Androgen Receptor Antagonist Product and Services
7.9.4 Kintor Pharma Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Kintor Pharma Recent Developments/Updates
7.9.6 Kintor Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Androgen Receptor Antagonist Industry Chain
8.2 Androgen Receptor Antagonist Upstream Analysis
8.2.1 Androgen Receptor Antagonist Core Raw Materials
8.2.2 Main Manufacturers of Androgen Receptor Antagonist Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Androgen Receptor Antagonist Production Mode
8.6 Androgen Receptor Antagonist Procurement Model
8.7 Androgen Receptor Antagonist Industry Sales Model and Sales Channels
8.7.1 Androgen Receptor Antagonist Sales Model
8.7.2 Androgen Receptor Antagonist Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Androgen Receptor Antagonist Introduction
1.2 World Androgen Receptor Antagonist Supply & Forecast
1.2.1 World Androgen Receptor Antagonist Production Value (2018 & 2022 & 2029)
1.2.2 World Androgen Receptor Antagonist Production (2018-2029)
1.2.3 World Androgen Receptor Antagonist Pricing Trends (2018-2029)
1.3 World Androgen Receptor Antagonist Production by Region (Based on Production Site)
1.3.1 World Androgen Receptor Antagonist Production Value by Region (2018-2029)
1.3.2 World Androgen Receptor Antagonist Production by Region (2018-2029)
1.3.3 World Androgen Receptor Antagonist Average Price by Region (2018-2029)
1.3.4 North America Androgen Receptor Antagonist Production (2018-2029)
1.3.5 Europe Androgen Receptor Antagonist Production (2018-2029)
1.3.6 China Androgen Receptor Antagonist Production (2018-2029)
1.3.7 Japan Androgen Receptor Antagonist Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Androgen Receptor Antagonist Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Androgen Receptor Antagonist Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Androgen Receptor Antagonist Demand (2018-2029)
2.2 World Androgen Receptor Antagonist Consumption by Region
2.2.1 World Androgen Receptor Antagonist Consumption by Region (2018-2023)
2.2.2 World Androgen Receptor Antagonist Consumption Forecast by Region (2024-2029)
2.3 United States Androgen Receptor Antagonist Consumption (2018-2029)
2.4 China Androgen Receptor Antagonist Consumption (2018-2029)
2.5 Europe Androgen Receptor Antagonist Consumption (2018-2029)
2.6 Japan Androgen Receptor Antagonist Consumption (2018-2029)
2.7 South Korea Androgen Receptor Antagonist Consumption (2018-2029)
2.8 ASEAN Androgen Receptor Antagonist Consumption (2018-2029)
2.9 India Androgen Receptor Antagonist Consumption (2018-2029)
3 WORLD ANDROGEN RECEPTOR ANTAGONIST MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Androgen Receptor Antagonist Production Value by Manufacturer (2018-2023)
3.2 World Androgen Receptor Antagonist Production by Manufacturer (2018-2023)
3.3 World Androgen Receptor Antagonist Average Price by Manufacturer (2018-2023)
3.4 Androgen Receptor Antagonist Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Androgen Receptor Antagonist Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Androgen Receptor Antagonist in 2022
3.5.3 Global Concentration Ratios (CR8) for Androgen Receptor Antagonist in 2022
3.6 Androgen Receptor Antagonist Market: Overall Company Footprint Analysis
3.6.1 Androgen Receptor Antagonist Market: Region Footprint
3.6.2 Androgen Receptor Antagonist Market: Company Product Type Footprint
3.6.3 Androgen Receptor Antagonist Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Androgen Receptor Antagonist Production Value Comparison
4.1.1 United States VS China: Androgen Receptor Antagonist Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Androgen Receptor Antagonist Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Androgen Receptor Antagonist Production Comparison
4.2.1 United States VS China: Androgen Receptor Antagonist Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Androgen Receptor Antagonist Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Androgen Receptor Antagonist Consumption Comparison
4.3.1 United States VS China: Androgen Receptor Antagonist Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Androgen Receptor Antagonist Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Androgen Receptor Antagonist Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Androgen Receptor Antagonist Production Value (2018-2023)
4.4.3 United States Based Manufacturers Androgen Receptor Antagonist Production (2018-2023)
4.5 China Based Androgen Receptor Antagonist Manufacturers and Market Share
4.5.1 China Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Androgen Receptor Antagonist Production Value (2018-2023)
4.5.3 China Based Manufacturers Androgen Receptor Antagonist Production (2018-2023)
4.6 Rest of World Based Androgen Receptor Antagonist Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Androgen Receptor Antagonist Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Androgen Receptor Antagonist Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Androgen Receptor Antagonist Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 First Generation Inhibitors
5.2.2 Second Generation Inhibitors
5.3 Market Segment by Type
5.3.1 World Androgen Receptor Antagonist Production by Type (2018-2029)
5.3.2 World Androgen Receptor Antagonist Production Value by Type (2018-2029)
5.3.3 World Androgen Receptor Antagonist Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Androgen Receptor Antagonist Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Prostate Cancer
6.2.2 Breast Cancer
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Androgen Receptor Antagonist Production by Application (2018-2029)
6.3.2 World Androgen Receptor Antagonist Production Value by Application (2018-2029)
6.3.3 World Androgen Receptor Antagonist Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck & Co., Inc
7.1.1 Merck & Co., Inc Details
7.1.2 Merck & Co., Inc Major Business
7.1.3 Merck & Co., Inc Androgen Receptor Antagonist Product and Services
7.1.4 Merck & Co., Inc Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck & Co., Inc Recent Developments/Updates
7.1.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi Androgen Receptor Antagonist Product and Services
7.2.4 Sanofi Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 Astellas Pharma Inc
7.3.1 Astellas Pharma Inc Details
7.3.2 Astellas Pharma Inc Major Business
7.3.3 Astellas Pharma Inc Androgen Receptor Antagonist Product and Services
7.3.4 Astellas Pharma Inc Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Astellas Pharma Inc Recent Developments/Updates
7.3.6 Astellas Pharma Inc Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Androgen Receptor Antagonist Product and Services
7.4.4 Pfizer Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Details
7.5.2 Johnson & Johnson Major Business
7.5.3 Johnson & Johnson Androgen Receptor Antagonist Product and Services
7.5.4 Johnson & Johnson Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Johnson & Johnson Recent Developments/Updates
7.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.6 Bayer
7.6.1 Bayer Details
7.6.2 Bayer Major Business
7.6.3 Bayer Androgen Receptor Antagonist Product and Services
7.6.4 Bayer Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bayer Recent Developments/Updates
7.6.6 Bayer Competitive Strengths & Weaknesses
7.7 Hinova
7.7.1 Hinova Details
7.7.2 Hinova Major Business
7.7.3 Hinova Androgen Receptor Antagonist Product and Services
7.7.4 Hinova Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Hinova Recent Developments/Updates
7.7.6 Hinova Competitive Strengths & Weaknesses
7.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd
7.8.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Details
7.8.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
7.8.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product and Services
7.8.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
7.8.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd Competitive Strengths & Weaknesses
7.9 Kintor Pharma
7.9.1 Kintor Pharma Details
7.9.2 Kintor Pharma Major Business
7.9.3 Kintor Pharma Androgen Receptor Antagonist Product and Services
7.9.4 Kintor Pharma Androgen Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Kintor Pharma Recent Developments/Updates
7.9.6 Kintor Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Androgen Receptor Antagonist Industry Chain
8.2 Androgen Receptor Antagonist Upstream Analysis
8.2.1 Androgen Receptor Antagonist Core Raw Materials
8.2.2 Main Manufacturers of Androgen Receptor Antagonist Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Androgen Receptor Antagonist Production Mode
8.6 Androgen Receptor Antagonist Procurement Model
8.7 Androgen Receptor Antagonist Industry Sales Model and Sales Channels
8.7.1 Androgen Receptor Antagonist Sales Model
8.7.2 Androgen Receptor Antagonist Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Androgen Receptor Antagonist Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Androgen Receptor Antagonist Production Value by Region (2018-2023) & (USD Million)
Table 3. World Androgen Receptor Antagonist Production Value by Region (2024-2029) & (USD Million)
Table 4. World Androgen Receptor Antagonist Production Value Market Share by Region (2018-2023)
Table 5. World Androgen Receptor Antagonist Production Value Market Share by Region (2024-2029)
Table 6. World Androgen Receptor Antagonist Production by Region (2018-2023) & (K Units)
Table 7. World Androgen Receptor Antagonist Production by Region (2024-2029) & (K Units)
Table 8. World Androgen Receptor Antagonist Production Market Share by Region (2018-2023)
Table 9. World Androgen Receptor Antagonist Production Market Share by Region (2024-2029)
Table 10. World Androgen Receptor Antagonist Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Androgen Receptor Antagonist Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Androgen Receptor Antagonist Major Market Trends
Table 13. World Androgen Receptor Antagonist Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Androgen Receptor Antagonist Consumption by Region (2018-2023) & (K Units)
Table 15. World Androgen Receptor Antagonist Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Androgen Receptor Antagonist Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Androgen Receptor Antagonist Producers in 2022
Table 18. World Androgen Receptor Antagonist Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Androgen Receptor Antagonist Producers in 2022
Table 20. World Androgen Receptor Antagonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Androgen Receptor Antagonist Company Evaluation Quadrant
Table 22. World Androgen Receptor Antagonist Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Androgen Receptor Antagonist Production Site of Key Manufacturer
Table 24. Androgen Receptor Antagonist Market: Company Product Type Footprint
Table 25. Androgen Receptor Antagonist Market: Company Product Application Footprint
Table 26. Androgen Receptor Antagonist Competitive Factors
Table 27. Androgen Receptor Antagonist New Entrant and Capacity Expansion Plans
Table 28. Androgen Receptor Antagonist Mergers & Acquisitions Activity
Table 29. United States VS China Androgen Receptor Antagonist Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Androgen Receptor Antagonist Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Androgen Receptor Antagonist Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Androgen Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Androgen Receptor Antagonist Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Androgen Receptor Antagonist Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Androgen Receptor Antagonist Production Market Share (2018-2023)
Table 37. China Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Androgen Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Androgen Receptor Antagonist Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Androgen Receptor Antagonist Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Androgen Receptor Antagonist Production Market Share (2018-2023)
Table 42. Rest of World Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Androgen Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Androgen Receptor Antagonist Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Androgen Receptor Antagonist Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Androgen Receptor Antagonist Production Market Share (2018-2023)
Table 47. World Androgen Receptor Antagonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Androgen Receptor Antagonist Production by Type (2018-2023) & (K Units)
Table 49. World Androgen Receptor Antagonist Production by Type (2024-2029) & (K Units)
Table 50. World Androgen Receptor Antagonist Production Value by Type (2018-2023) & (USD Million)
Table 51. World Androgen Receptor Antagonist Production Value by Type (2024-2029) & (USD Million)
Table 52. World Androgen Receptor Antagonist Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Androgen Receptor Antagonist Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Androgen Receptor Antagonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Androgen Receptor Antagonist Production by Application (2018-2023) & (K Units)
Table 56. World Androgen Receptor Antagonist Production by Application (2024-2029) & (K Units)
Table 57. World Androgen Receptor Antagonist Production Value by Application (2018-2023) & (USD Million)
Table 58. World Androgen Receptor Antagonist Production Value by Application (2024-2029) & (USD Million)
Table 59. World Androgen Receptor Antagonist Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Androgen Receptor Antagonist Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co., Inc Major Business
Table 63. Merck & Co., Inc Androgen Receptor Antagonist Product and Services
Table 64. Merck & Co., Inc Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck & Co., Inc Recent Developments/Updates
Table 66. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Major Business
Table 69. Sanofi Androgen Receptor Antagonist Product and Services
Table 70. Sanofi Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Recent Developments/Updates
Table 72. Sanofi Competitive Strengths & Weaknesses
Table 73. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 74. Astellas Pharma Inc Major Business
Table 75. Astellas Pharma Inc Androgen Receptor Antagonist Product and Services
Table 76. Astellas Pharma Inc Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Astellas Pharma Inc Recent Developments/Updates
Table 78. Astellas Pharma Inc Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Androgen Receptor Antagonist Product and Services
Table 82. Pfizer Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 86. Johnson & Johnson Major Business
Table 87. Johnson & Johnson Androgen Receptor Antagonist Product and Services
Table 88. Johnson & Johnson Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Johnson & Johnson Competitive Strengths & Weaknesses
Table 91. Bayer Basic Information, Manufacturing Base and Competitors
Table 92. Bayer Major Business
Table 93. Bayer Androgen Receptor Antagonist Product and Services
Table 94. Bayer Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bayer Recent Developments/Updates
Table 96. Bayer Competitive Strengths & Weaknesses
Table 97. Hinova Basic Information, Manufacturing Base and Competitors
Table 98. Hinova Major Business
Table 99. Hinova Androgen Receptor Antagonist Product and Services
Table 100. Hinova Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Hinova Recent Developments/Updates
Table 102. Hinova Competitive Strengths & Weaknesses
Table 103. Jiangsu Hengrui Pharmaceuticals Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
Table 105. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product and Services
Table 106. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
Table 108. Kintor Pharma Basic Information, Manufacturing Base and Competitors
Table 109. Kintor Pharma Major Business
Table 110. Kintor Pharma Androgen Receptor Antagonist Product and Services
Table 111. Kintor Pharma Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of Androgen Receptor Antagonist Upstream (Raw Materials)
Table 113. Androgen Receptor Antagonist Typical Customers
Table 114. Androgen Receptor Antagonist Typical Distributors
Table 1. World Androgen Receptor Antagonist Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Androgen Receptor Antagonist Production Value by Region (2018-2023) & (USD Million)
Table 3. World Androgen Receptor Antagonist Production Value by Region (2024-2029) & (USD Million)
Table 4. World Androgen Receptor Antagonist Production Value Market Share by Region (2018-2023)
Table 5. World Androgen Receptor Antagonist Production Value Market Share by Region (2024-2029)
Table 6. World Androgen Receptor Antagonist Production by Region (2018-2023) & (K Units)
Table 7. World Androgen Receptor Antagonist Production by Region (2024-2029) & (K Units)
Table 8. World Androgen Receptor Antagonist Production Market Share by Region (2018-2023)
Table 9. World Androgen Receptor Antagonist Production Market Share by Region (2024-2029)
Table 10. World Androgen Receptor Antagonist Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Androgen Receptor Antagonist Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Androgen Receptor Antagonist Major Market Trends
Table 13. World Androgen Receptor Antagonist Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Androgen Receptor Antagonist Consumption by Region (2018-2023) & (K Units)
Table 15. World Androgen Receptor Antagonist Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Androgen Receptor Antagonist Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Androgen Receptor Antagonist Producers in 2022
Table 18. World Androgen Receptor Antagonist Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Androgen Receptor Antagonist Producers in 2022
Table 20. World Androgen Receptor Antagonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Androgen Receptor Antagonist Company Evaluation Quadrant
Table 22. World Androgen Receptor Antagonist Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Androgen Receptor Antagonist Production Site of Key Manufacturer
Table 24. Androgen Receptor Antagonist Market: Company Product Type Footprint
Table 25. Androgen Receptor Antagonist Market: Company Product Application Footprint
Table 26. Androgen Receptor Antagonist Competitive Factors
Table 27. Androgen Receptor Antagonist New Entrant and Capacity Expansion Plans
Table 28. Androgen Receptor Antagonist Mergers & Acquisitions Activity
Table 29. United States VS China Androgen Receptor Antagonist Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Androgen Receptor Antagonist Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Androgen Receptor Antagonist Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Androgen Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Androgen Receptor Antagonist Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Androgen Receptor Antagonist Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Androgen Receptor Antagonist Production Market Share (2018-2023)
Table 37. China Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Androgen Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Androgen Receptor Antagonist Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Androgen Receptor Antagonist Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Androgen Receptor Antagonist Production Market Share (2018-2023)
Table 42. Rest of World Based Androgen Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Androgen Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Androgen Receptor Antagonist Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Androgen Receptor Antagonist Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Androgen Receptor Antagonist Production Market Share (2018-2023)
Table 47. World Androgen Receptor Antagonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Androgen Receptor Antagonist Production by Type (2018-2023) & (K Units)
Table 49. World Androgen Receptor Antagonist Production by Type (2024-2029) & (K Units)
Table 50. World Androgen Receptor Antagonist Production Value by Type (2018-2023) & (USD Million)
Table 51. World Androgen Receptor Antagonist Production Value by Type (2024-2029) & (USD Million)
Table 52. World Androgen Receptor Antagonist Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Androgen Receptor Antagonist Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Androgen Receptor Antagonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Androgen Receptor Antagonist Production by Application (2018-2023) & (K Units)
Table 56. World Androgen Receptor Antagonist Production by Application (2024-2029) & (K Units)
Table 57. World Androgen Receptor Antagonist Production Value by Application (2018-2023) & (USD Million)
Table 58. World Androgen Receptor Antagonist Production Value by Application (2024-2029) & (USD Million)
Table 59. World Androgen Receptor Antagonist Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Androgen Receptor Antagonist Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co., Inc Major Business
Table 63. Merck & Co., Inc Androgen Receptor Antagonist Product and Services
Table 64. Merck & Co., Inc Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck & Co., Inc Recent Developments/Updates
Table 66. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Major Business
Table 69. Sanofi Androgen Receptor Antagonist Product and Services
Table 70. Sanofi Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Recent Developments/Updates
Table 72. Sanofi Competitive Strengths & Weaknesses
Table 73. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 74. Astellas Pharma Inc Major Business
Table 75. Astellas Pharma Inc Androgen Receptor Antagonist Product and Services
Table 76. Astellas Pharma Inc Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Astellas Pharma Inc Recent Developments/Updates
Table 78. Astellas Pharma Inc Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Androgen Receptor Antagonist Product and Services
Table 82. Pfizer Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 86. Johnson & Johnson Major Business
Table 87. Johnson & Johnson Androgen Receptor Antagonist Product and Services
Table 88. Johnson & Johnson Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Johnson & Johnson Competitive Strengths & Weaknesses
Table 91. Bayer Basic Information, Manufacturing Base and Competitors
Table 92. Bayer Major Business
Table 93. Bayer Androgen Receptor Antagonist Product and Services
Table 94. Bayer Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bayer Recent Developments/Updates
Table 96. Bayer Competitive Strengths & Weaknesses
Table 97. Hinova Basic Information, Manufacturing Base and Competitors
Table 98. Hinova Major Business
Table 99. Hinova Androgen Receptor Antagonist Product and Services
Table 100. Hinova Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Hinova Recent Developments/Updates
Table 102. Hinova Competitive Strengths & Weaknesses
Table 103. Jiangsu Hengrui Pharmaceuticals Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
Table 105. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Product and Services
Table 106. Jiangsu Hengrui Pharmaceuticals Co., Ltd Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
Table 108. Kintor Pharma Basic Information, Manufacturing Base and Competitors
Table 109. Kintor Pharma Major Business
Table 110. Kintor Pharma Androgen Receptor Antagonist Product and Services
Table 111. Kintor Pharma Androgen Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Global Key Players of Androgen Receptor Antagonist Upstream (Raw Materials)
Table 113. Androgen Receptor Antagonist Typical Customers
Table 114. Androgen Receptor Antagonist Typical Distributors
LIST OF FIGURES
Figure 1. Androgen Receptor Antagonist Picture
Figure 2. World Androgen Receptor Antagonist Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Androgen Receptor Antagonist Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Androgen Receptor Antagonist Production (2018-2029) & (K Units)
Figure 5. World Androgen Receptor Antagonist Average Price (2018-2029) & (US$/Unit)
Figure 6. World Androgen Receptor Antagonist Production Value Market Share by Region (2018-2029)
Figure 7. World Androgen Receptor Antagonist Production Market Share by Region (2018-2029)
Figure 8. North America Androgen Receptor Antagonist Production (2018-2029) & (K Units)
Figure 9. Europe Androgen Receptor Antagonist Production (2018-2029) & (K Units)
Figure 10. China Androgen Receptor Antagonist Production (2018-2029) & (K Units)
Figure 11. Japan Androgen Receptor Antagonist Production (2018-2029) & (K Units)
Figure 12. Androgen Receptor Antagonist Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 15. World Androgen Receptor Antagonist Consumption Market Share by Region (2018-2029)
Figure 16. United States Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 17. China Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 18. Europe Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 19. Japan Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 20. South Korea Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 22. India Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Androgen Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Androgen Receptor Antagonist Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Androgen Receptor Antagonist Markets in 2022
Figure 26. United States VS China: Androgen Receptor Antagonist Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Androgen Receptor Antagonist Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Androgen Receptor Antagonist Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Androgen Receptor Antagonist Production Market Share 2022
Figure 30. China Based Manufacturers Androgen Receptor Antagonist Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Androgen Receptor Antagonist Production Market Share 2022
Figure 32. World Androgen Receptor Antagonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Androgen Receptor Antagonist Production Value Market Share by Type in 2022
Figure 34. First Generation Inhibitors
Figure 35. Second Generation Inhibitors
Figure 36. World Androgen Receptor Antagonist Production Market Share by Type (2018-2029)
Figure 37. World Androgen Receptor Antagonist Production Value Market Share by Type (2018-2029)
Figure 38. World Androgen Receptor Antagonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Androgen Receptor Antagonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Androgen Receptor Antagonist Production Value Market Share by Application in 2022
Figure 41. Prostate Cancer
Figure 42. Breast Cancer
Figure 43. Other
Figure 44. World Androgen Receptor Antagonist Production Market Share by Application (2018-2029)
Figure 45. World Androgen Receptor Antagonist Production Value Market Share by Application (2018-2029)
Figure 46. World Androgen Receptor Antagonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Androgen Receptor Antagonist Industry Chain
Figure 48. Androgen Receptor Antagonist Procurement Model
Figure 49. Androgen Receptor Antagonist Sales Model
Figure 50. Androgen Receptor Antagonist Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Androgen Receptor Antagonist Picture
Figure 2. World Androgen Receptor Antagonist Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Androgen Receptor Antagonist Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Androgen Receptor Antagonist Production (2018-2029) & (K Units)
Figure 5. World Androgen Receptor Antagonist Average Price (2018-2029) & (US$/Unit)
Figure 6. World Androgen Receptor Antagonist Production Value Market Share by Region (2018-2029)
Figure 7. World Androgen Receptor Antagonist Production Market Share by Region (2018-2029)
Figure 8. North America Androgen Receptor Antagonist Production (2018-2029) & (K Units)
Figure 9. Europe Androgen Receptor Antagonist Production (2018-2029) & (K Units)
Figure 10. China Androgen Receptor Antagonist Production (2018-2029) & (K Units)
Figure 11. Japan Androgen Receptor Antagonist Production (2018-2029) & (K Units)
Figure 12. Androgen Receptor Antagonist Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 15. World Androgen Receptor Antagonist Consumption Market Share by Region (2018-2029)
Figure 16. United States Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 17. China Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 18. Europe Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 19. Japan Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 20. South Korea Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 22. India Androgen Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Androgen Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Androgen Receptor Antagonist Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Androgen Receptor Antagonist Markets in 2022
Figure 26. United States VS China: Androgen Receptor Antagonist Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Androgen Receptor Antagonist Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Androgen Receptor Antagonist Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Androgen Receptor Antagonist Production Market Share 2022
Figure 30. China Based Manufacturers Androgen Receptor Antagonist Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Androgen Receptor Antagonist Production Market Share 2022
Figure 32. World Androgen Receptor Antagonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Androgen Receptor Antagonist Production Value Market Share by Type in 2022
Figure 34. First Generation Inhibitors
Figure 35. Second Generation Inhibitors
Figure 36. World Androgen Receptor Antagonist Production Market Share by Type (2018-2029)
Figure 37. World Androgen Receptor Antagonist Production Value Market Share by Type (2018-2029)
Figure 38. World Androgen Receptor Antagonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Androgen Receptor Antagonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Androgen Receptor Antagonist Production Value Market Share by Application in 2022
Figure 41. Prostate Cancer
Figure 42. Breast Cancer
Figure 43. Other
Figure 44. World Androgen Receptor Antagonist Production Market Share by Application (2018-2029)
Figure 45. World Androgen Receptor Antagonist Production Value Market Share by Application (2018-2029)
Figure 46. World Androgen Receptor Antagonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Androgen Receptor Antagonist Industry Chain
Figure 48. Androgen Receptor Antagonist Procurement Model
Figure 49. Androgen Receptor Antagonist Sales Model
Figure 50. Androgen Receptor Antagonist Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
